학술논문

Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
Document Type
Article
Source
Journal of Nuclear Medicine; Aug2018, Vol. 59 Issue 8, p1234-1242, 9p, 2 Charts, 7 Graphs
Subject
Language
ISSN
01615505